Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
Programmed cell death protein 1 (PD-1) and its ligand PD-L1 have attracted wide attention from researchers in the field of immunotherapy. PD-1/PD-L1 have been shown to exist in many types of cells in addition to T lymphocytes, and studies have accordingly extended from their suppressive effect on T...
Main Authors: | Di Lu, Zhen Ni, Xiguang Liu, Siyang Feng, Xiaoying Dong, Xiaoshun Shi, Jianxue Zhai, Shijie Mai, Jianjun Jiang, Zhizhi Wang, Hua Wu, Kaican Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/1919082 |
Similar Items
-
Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
by: Di Lu, et al.
Published: (2020-05-01) -
Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
by: Xiaoshun Shi, et al.
Published: (2021-05-01) -
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
by: Hao Cai, et al.
Published: (2021-06-01) -
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
by: Weiting Qin, et al.
Published: (2019-10-01) -
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
by: Nicolas Villanueva, et al.
Published: (2018-09-01)